Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Evoke

William Hill owner says UK football stakes slimmer since Euro 2024

Evoke said its gaming division had strengthened but sports betting had ‘lagged’ over the first half of 2025.

Evening Standard · Aug 13, 2025

Sonicware's LIVEN Evoke is a "nostalgia-evoking ambient music box" fusing acoustic and electronic sounds

The next synth in the Japanese manufacturer's super-affordable LIVEN series is billed as a "deeply expressive tool for composing cinematic ambient and post-classical music"

MusicRadar · Jun 17, 2025

William Hill owner says UK arm impacted by tighter gambling restrictions

It came as Evoke revealed stronger revenues for the latest quarter.

Evening Standard · Apr 25, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Evoke to cut costs further as it cautions over a slow start to 2025

William Hill gambling group Evoke rebranded from 888 last year.

Evening Standard · Mar 26, 2025

William Hill parent company turnaround ‘working’ as profit set to beat forecasts

Evoke, which also owns the 888 gambling brands, expects to see booming revenue growth for the final part of 2024.

Evening Standard · Jan 17, 2025

Gambling firm appears to trivialise Lebanon pager blasts in social media post

London-listed Evoke, which owns William Hill, apologises for post on Israeli Facebook page linking to job ads

The Guardian - UK · Sep 19, 2024

William Hill owner’s turnaround plan falters as losses widen

Gambling group Evoke – formerly 888 – reports losses of £147m after taking £72m hit from US market retreat

The Guardian - UK · Aug 15, 2024

Read news from The Economist, FT, and more,
with one subscription

Evoke To Electrify Long-Distance Touring With 370-Mile 6061-GT

Evoke Motorcycles is gearing up to launch its newest long-distance electric tourer, the 6061-GT, in the US market.

RideApart · Nov 3, 2023

Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal Spray

The FDA has granted new drug product exclusivity to Evoke Pharma Inc's (NASDAQ:EVOK) Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Evoke now has exclusive marketing rights over three (3) years from the original date of approval under the Hatch-Waxman Act to protect the product from…

Benzinga · Apr 26, 2022

1 2

Coverage From

People

Reeves

237 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.